Top Medical Technologies Startups in 2024

We are a healthcare and biotech company specialising in personalised, genetics-based solutions for chronic conditions such as weight management, mental health, hormonal imbalances, ADHD, and more. Operating across Australia, New Zealand, and the Polynesian islands, we utilize advanced genetic testing and biotechnology to provide insights into pharmacogenetics, nutrigenomics, and metabolic health, helping patients take control of their well-being. Our experienced team of doctors, nurse practitioners, geneticists and dietitians work with patients to create individualized treatment plans that address their unique health needs. By combining genetic data with the latest in biotechnology, we offer targeted, science-driven care that tackles the root causes of chronic health issues. At Nume, we take a proactive approach to healthcare, using AI and genetic insights to deliver personalized programs. These programs include everything from medical treatments and lifestyle modifications to nutrition plans, all designed for long-term health improvement. Whether patients are seeking help with weight loss, managing mental health challenges, or addressing chronic hormonal conditions, we provide comprehensive solutions that are both effective and sustainable. Our telehealth platform makes healthcare more accessible than ever, offering video consultations that bring expert care directly to patients’ homes. By eliminating the need for in-person visits, we ensure that people across Oceania can easily access top-tier, ongoing healthcare, regardless of their location. Nume is at the forefront of integrating biotech with personalized care. We are committed to making healthcare more accessible, compassionate, and effective, driven by innovation and grounded in science. Our mission is to empower individuals with the knowledge and tools to lead healthier lives through cutting-edge, research-based solutions.

Janitri is a leading innovator in the medical device industry, dedicated to developing cutting-edge solutions that improve patient outcomes and streamline healthcare delivery.

Our first products are a digital personalisation engine that recommends contraception types and brands based on our proprietary algorithm and a genetic test that can identify a woman's specific risks and predispositions. Our mission is to revolutionise how women decide about their contraception, empowering them to make the most suitable choice to their preference and unique biology. Our customers are all women of reproductive age (15-49). Women already using contraception but are dissatisfied, deciding for the first time, or had their life circumstances changed. (eg. pregnancy, relationship changes). Another key customer persona is parents helping their daughters choose contraception. Our partners will involve clinics and telehealth companies as personalised contraception prescribing will enable them to provide higher quality care at reduced costs.

We develop cutting edge medical devices that leverage machine learning and artificial intelligence for healthcare.

Entia is making life better for people receiving cancer treatment. We develop a range of virtual oncology solutions comprising novel self-testing blood analysers, apps and digital health solutions that seamlessly integrate with healthcare systems. Our ambitious team works on patient-centric designs, innovative technology and cutting edge medical science. Through these, we are redefining cancer care to empower patients and physicians, and benefit the wider global healthcare community.

Pulse, are the leading global provider of multichannel marketing content creation and automation and artificial intelligence technology, for life science companies. Using our customer centric approach, combined with compelling creative and groundbreaking technology, we work with some of the worlds largest healthcare organisations to create remarkable experiences for healthcare professionals and patients. Our CLM builder platform, Heartbeat™, is a cloud-based, multichannel marketing automation platform – optimised for Veeva customers and adopted by leading global pharmaceutical companies. Heartbeat™ seamlessly integrates into Veeva Vault and automates common tasks across the end-to-end content supply chain for CLM, Engage, Approved Email and MyInsights. We are at the cutting edge of transforming healthcare for the benefit of patients. We are always on the lookout for talented individuals to come and help us drive the change.

Respirer Living Sciences, a climate science startup that builds low-cost, sensor-based air quality monitoring devices and uses IoT and Big Data to provide real-time air quality data analytics. Recent updates about the company can be seen here: news.microsoft.com/en-in/features/democratizing-air-pollution-data-so-india-c… We are a central government (DPIIT) approved startup having received the IMB (Inter-Ministerial Board) certification (atmos.urbansciences.in/images/DIPP5311_80IAC.pdf) - 220 companies in India out of the 22,000 startups have received this certification. We are working in two areas: 1. Building a Real-time Low-Cost scientifically validated air quality monitoring network. This includes the long-range wireless sensing devices (using GSM & NBIoT) and a streaming data analytics platform. The focus is on building citizen-science based solutions and assisting with recommendations for policy makers. More about the working prototype can be read here: yourstory.com/socialstory/2020/01/mumbai-startup-device-air-pollution-data and the prototype can be seen here: atmos.urbansciences.in 2. We are also working on helping build machine learning algorithms for translational cancer research. Specifically, this means using genomics as well as clinical patient data to better assist in patient-centric treatment decision making.

Founded in 2021 by 4 alumni from IIT Roorkee, IIT(ISM) Dhanbad, NIT Bhopal with a vision to develop medical technologies and devices indigenously to make India self-sufficient in the health-tech domain. We intent to make healthcare more accessible and affordable to the masses in India. Currently, we are incubated at Startup Innovation and Incubation Center (SIIC) IIT Kanpur.

CANCER FUND is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at cancerfund.com.

Motilent champions the use of novel MRI post-processing software as a cheaper and safer biomarker for Gastrointestinal and Bowel Disorders, providing quantitative end points for research, drug development and clinical decision-making.